Bioequivalence of Related GelShield Ⓡ Sustained-release Formulations of Metformin: A Pooled Pharmaco...
Bioequivalence of Related GelShield Ⓡ Sustained-release Formulations of Metformin: A Pooled Pharmacokinetic Analysis
About this item
Full title
Author / Creator
Publisher
United States: Elsevier Inc
Journal title
Language
English
Formats
Publication information
Publisher
United States: Elsevier Inc
Subjects
More information
Scope and Contents
Contents
AbstractPurposeGlucophage Ⓡ (Merck Healthcare KGaA, Darmstadt, Germany) is the originator brand of metformin hydrochloride, an oral antidiabetic drug. Metformin is recommended in guidelines as first-line treatment of type 2 diabetes mellitus and increasingly in related insulin-resistant conditions, such as prediabetes and polycystic ovary syndrome....
Alternative Titles
Full title
Bioequivalence of Related GelShield Ⓡ Sustained-release Formulations of Metformin: A Pooled Pharmacokinetic Analysis
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_3049720233
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_3049720233
Other Identifiers
ISSN
0149-2918,1879-114X
E-ISSN
1879-114X
DOI
10.1016/j.clinthera.2024.03.011
